Liyong Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liyong Zhong has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Hong-Juan Fang
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
3 shared publicationsHongjuan Fang
Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China
3 shared publicationsHong Fan
2 shared publications- Hongjuan Fang
Department of Endocrinology Aviation General Hospital Beijing China
2 shared publications Huanwen Wu
2 shared publicationsJian Xu
2 shared publications
Latest Publications
- Open Access
- 25 November 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16  (1)
Identifying predictive factors for recurrence risk in pediatric craniopharyngioma after surgery using a clinical prediction model
Background Craniopharyngioma (CP) tumors are histologically benign (WHO grade I) and can occur at any age. Postoperative pediatric craniopharyngioma (CO-CP) patients have a high long-term survival rate but are at risk of poor quality of life. In this study, we propose a novel nomogram that graphically expresses the numerical relationship between patients with postoperative CO-CP and risk factors for recurrence. Methods A retrospective analysis was conducted on data from 192 patients treated at XXX Hospital between January 2012 and July 2019. Utilizing R software, a random sampling method was employed to select 115 patients (3/5) for the training cohort and 77 patients (2/5) for the internal test cohort. LASSO regression analysis identified significant risk factors for recurrence, leading to the construction of a nomogram based on these factors. The accuracy of the nomogram was evaluated using receiver operating characteristic (ROC) curves and clinical decision curve analysis (DCA). Results The analysis revealed that tumor diameter was the most significant risk factor for recurrence in post-operative CO-CP patients (95% CI 2.72–35.01, OR = 9.22). Other notable risk factors included visual disturbances (95% CI 0.98–17.35, OR = 4.13), preoperative neuroendocrine function impairment scoring (95% CI 0.76–8.37, OR = 2.45), and the extent of resection (gross-total resection: 95% CI 0.08–0.86, OR = 0.27). The ROC analysis indicated areas under the curve of 0.777 and 0.766 for the training and internal test cohorts, respectively. The clinical DCA curves associated with the nomogram in the training and internal test cohorts ranged from 2 to 78% and 1%–80%, respectively. Conclusions Our proposed nomogram accurately predicts risk factors for postoperative CO-CP recurrence. By incorporating LASSO-selected endocrinological variables, it builds on prior classifications such as Puget et al. (2007) and may serve as a practical tool for identifying patients at increased risk of recurrence.
- 25 November 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16  (1)
Open AccessIdentifying predictive factors for recurrence risk in pediatric craniopharyngioma after surgery using a clinical prediction model
Background Craniopharyngioma (CP) tumors are histologically benign (WHO grade I) and can occur at any age. Postoperative pediatric craniopharyngioma (CO-CP) patients have a high long-term survival rate but are at risk of poor quality of life. In this study, we propose a novel nomogram that graphically expresses the numerical relationship between patients with postoperative CO-CP and risk factors for recurrence. Methods A retrospective analysis was conducted on data from 192 patients treated at XXX Hospital between January 2012 and July 2019. Utilizing R software, a random sampling method was employed to select 115 patients (3/5) for the training cohort and 77 patients (2/5) for the internal test cohort. LASSO regression analysis identified significant risk factors for recurrence, leading to the construction of a nomogram based on these factors. The accuracy of the nomogram was evaluated using receiver operating characteristic (ROC) curves and clinical decision curve analysis (DCA). Results The analysis revealed that tumor diameter was the most significant risk factor for recurrence in post-operative CO-CP patients (95% CI 2.72–35.01, OR = 9.22). Other notable risk factors included visual disturbances (95% CI 0.98–17.35, OR = 4.13), preoperative neuroendocrine function impairment scoring (95% CI 0.76–8.37, OR = 2.45), and the extent of resection (gross-total resection: 95% CI 0.08–0.86, OR = 0.27). The ROC analysis indicated areas under the curve of 0.777 and 0.766 for the training and internal test cohorts, respectively. The clinical DCA curves associated with the nomogram in the training and internal test cohorts ranged from 2 to 78% and 1%–80%, respectively. Conclusions Our proposed nomogram accurately predicts risk factors for postoperative CO-CP recurrence. By incorporating LASSO-selected endocrinological variables, it builds on prior classifications such as Puget et al. (2007) and may serve as a practical tool for identifying patients at increased risk of recurrence.
- Open Access
- 11 September 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 133  (18) , 2244-2246
Prognostic value of admission hyperglycemia on outcomes of thrombolysis in ischemic stroke patients with or without diabetes
- 11 September 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 133  (18) , 2244-2246
Open AccessPrognostic value of admission hyperglycemia on outcomes of thrombolysis in ischemic stroke patients with or without diabetes
- 1 March 2020
- Published by Elsevier in World Neurosurgery
- Vol. 135, e194-e201
Malignant Craniopharyngioma: A Report of Seven Cases and Review of the Literature
- 1 March 2020
- Published by Elsevier in World Neurosurgery
- Vol. 135, e194-e201
Malignant Craniopharyngioma: A Report of Seven Cases and Review of the Literature
- 1 February 2020
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 501, 110660
Hepatic insulin resistance induced by mitochondrial oxidative stress can be ameliorated by sphingosine 1-phosphate
- 1 February 2020
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 501, 110660
Hepatic insulin resistance induced by mitochondrial oxidative stress can be ameliorated by sphingosine 1-phosphate
- 24 December 2019
- Published by Springer Nature in Endocrine
- Vol. 67  (2) , 433-441
Metabolic profiling of acromegaly using a GC–MS-based nontargeted metabolomic approach
Acromegaly is a rare disease caused by chronic hypersecretion of growth hormone, which leads to multiple comorbidities and reduced life expectancy. The objective of this study was to characterize the serum metabolic profiles of acromegaly patients and identify metabolic biomarkers using metabolomics.
- 24 December 2019
- Published by Springer Nature in Endocrine
- Vol. 67  (2) , 433-441
Metabolic profiling of acromegaly using a GC–MS-based nontargeted metabolomic approach
Acromegaly is a rare disease caused by chronic hypersecretion of growth hormone, which leads to multiple comorbidities and reduced life expectancy. The objective of this study was to characterize the serum metabolic profiles of acromegaly patients and identify metabolic biomarkers using metabolomics.
- 26 January 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32  (2) , 127-133
Comparative evaluation of neuroendocrine dysfunction in children with craniopharyngiomas before and after mass effects are removed
Objective: To compare the effects of mass effects in situ (MEIS) and after neurosurgery (ANS) on neuroendocrine function in children with craniopharyngioma. Methods: We retrospectively investigated 185 cases of children with craniopharyngioma who underwent neurosurgical treatment at the Beijing Tiantan Hospital from 2011 to 2016. The neuroendocrine function of patients was compared before and after tumor removal. Results: Compared with the MEIS, the incidence of growth hormone insulin-like growth factor 1 axis dysfunction (47.03% vs. 57.30%), pituitary-thyroid axis dysfunction (20.00% vs. 50.27%), pituitary-adrenal axis dysfunction (18.38% vs. 43.78%) and diabetes insipidus (26.49% vs. 44.86%) was significantly increased in the ANS status. The incidence of hyperprolactinemia significantly decreased from 28.11% in the MEIS status to 20.54% in the ANS status. Compared with the MEIS group, changes in appetite, development of diabetes insipidus, body temperature dysregulation, sleeping disorders, personality abnormalities and cognitive abnormalities were more frequent after ANS, yet no statistically significant differences were found. Conclusions: Endocrine dysfunction is common in children with craniopharyngioma. Both MEIS and ANS can be harmful to neuroendocrine function, and neurosurgical treatment may increase the level of neuroendocrine dysfunction.
- 26 January 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32  (2) , 127-133
Comparative evaluation of neuroendocrine dysfunction in children with craniopharyngiomas before and after mass effects are removed
Objective: To compare the effects of mass effects in situ (MEIS) and after neurosurgery (ANS) on neuroendocrine function in children with craniopharyngioma. Methods: We retrospectively investigated 185 cases of children with craniopharyngioma who underwent neurosurgical treatment at the Beijing Tiantan Hospital from 2011 to 2016. The neuroendocrine function of patients was compared before and after tumor removal. Results: Compared with the MEIS, the incidence of growth hormone insulin-like growth factor 1 axis dysfunction (47.03% vs. 57.30%), pituitary-thyroid axis dysfunction (20.00% vs. 50.27%), pituitary-adrenal axis dysfunction (18.38% vs. 43.78%) and diabetes insipidus (26.49% vs. 44.86%) was significantly increased in the ANS status. The incidence of hyperprolactinemia significantly decreased from 28.11% in the MEIS status to 20.54% in the ANS status. Compared with the MEIS group, changes in appetite, development of diabetes insipidus, body temperature dysregulation, sleeping disorders, personality abnormalities and cognitive abnormalities were more frequent after ANS, yet no statistically significant differences were found. Conclusions: Endocrine dysfunction is common in children with craniopharyngioma. Both MEIS and ANS can be harmful to neuroendocrine function, and neurosurgical treatment may increase the level of neuroendocrine dysfunction.
- Open Access
- 16 April 2018
- Published by Springer Nature in BMC Cancer
- Vol. 18  (1) , 422
Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies
The increasing epidemic proportions of diabetes mellitus (DM) are a major cause of premature illness and death. However, whether DM confers the same excess risk of gastrointestinal cancer for women as it does for men remains controversial. The purpose of this study was to estimate the relation between DM and gastrointestinal cancer in women compared with men after accounting for other major risk factors based on cohort studies. We performed a meta-analysis of cohort studies published through May 2017 from PubMed, Embase, and the Cochrane Library. Studies with cohort designs were stratified by sex and reported the relation between DM and esophageal cancer (EC), gastric cancer (GC), colorectal cancer (CRC), colon cancer (CC), rectal cancer (RC), hepatocellular carcinoma (HCC), or pancreatic cancer (PC) risk. The ratio of relative risk (RRR) between men and women was employed to measure the sex differences in the relation between DM and gastrointestinal cancer with a random effects model with inverse variance weighting. We included 38 cohort studies reporting data on 18,060,698 individuals. The pooled RRR indicated DM women was associated with an increased risk of GC (RRR: 1.14; 95%CI: 1.06–1.22; p < 0.001), while the risk of HCC was lower (RRR: 0.88; 95%CI: 0.79–0.99; p = 0.031) as compared with DM men. Further, there was no evidence of sex differences in the RRR between participants who had DM compared with those without DM for EC (p = 0.068), CRC (p = 0.618), and PC (p = 0.976). In addition, the pooled RRR showed a statistically significant association between DM and the risk of CC in women compared with men (RRR: 0.93; 95%CI: 0.86–1.00; p = 0.050), and there was no evidence of sex differences for RC among participants with DM compared to those without DM (p = 0.648). Finally, the sex differences of the comparison between DM and non-DM for gastrointestinal cancer risk at different sites were variable after stratification for different effect estimates. The findings of this study suggested female-to-male RRR of DM was increased for GC, while reduced for HCC and CC. However, there were no sex differences for the relation between DM and the risk of EC, CRC, PC, and RC.
- 16 April 2018
- Published by Springer Nature in BMC Cancer
- Vol. 18  (1) , 422
Open AccessDiabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies
The increasing epidemic proportions of diabetes mellitus (DM) are a major cause of premature illness and death. However, whether DM confers the same excess risk of gastrointestinal cancer for women as it does for men remains controversial. The purpose of this study was to estimate the relation between DM and gastrointestinal cancer in women compared with men after accounting for other major risk factors based on cohort studies. We performed a meta-analysis of cohort studies published through May 2017 from PubMed, Embase, and the Cochrane Library. Studies with cohort designs were stratified by sex and reported the relation between DM and esophageal cancer (EC), gastric cancer (GC), colorectal cancer (CRC), colon cancer (CC), rectal cancer (RC), hepatocellular carcinoma (HCC), or pancreatic cancer (PC) risk. The ratio of relative risk (RRR) between men and women was employed to measure the sex differences in the relation between DM and gastrointestinal cancer with a random effects model with inverse variance weighting. We included 38 cohort studies reporting data on 18,060,698 individuals. The pooled RRR indicated DM women was associated with an increased risk of GC (RRR: 1.14; 95%CI: 1.06–1.22; p < 0.001), while the risk of HCC was lower (RRR: 0.88; 95%CI: 0.79–0.99; p = 0.031) as compared with DM men. Further, there was no evidence of sex differences in the RRR between participants who had DM compared with those without DM for EC (p = 0.068), CRC (p = 0.618), and PC (p = 0.976). In addition, the pooled RRR showed a statistically significant association between DM and the risk of CC in women compared with men (RRR: 0.93; 95%CI: 0.86–1.00; p = 0.050), and there was no evidence of sex differences for RC among participants with DM compared to those without DM (p = 0.648). Finally, the sex differences of the comparison between DM and non-DM for gastrointestinal cancer risk at different sites were variable after stratification for different effect estimates. The findings of this study suggested female-to-male RRR of DM was increased for GC, while reduced for HCC and CC. However, there were no sex differences for the relation between DM and the risk of EC, CRC, PC, and RC.
- Open Access
- 29 September 2017
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 14  (6) , 5313-5320
Birth weight and type 2 diabetes: A meta‑analysis
The prevalence of T2DM is increasing around the world on a yearly basis. A meta‑analysis was conducted to analyze the association between birth weight and incidence of type 2 diabetes mellitus (T2DM). A literature search was performed from January 1990 to June 2016 in PubMed, ScienceDirect, SpringerLink, China National Knowledge Infrastructure and Chinese Biomedical Literature Database. After reviewing characteristics of all the included studies systematically, a meta‑analytical method was employed to calculate the pooled odds ratios (ORs) and associated 95% confidence intervals (CI) from random‑effects models. Heterogeneity was assessed by Q‑statistic test. Funnel plot, Begg's and Egger's linear regression tests were applied to evaluate publication bias. A sensitivity analysis was also performed to assess the robustness of results. According to inclusion and exclusion criteria, 8 studies were selected to be included in the meta‑analysis. Compared with normal birth weight (2,500‑4,000 g), low birth weight (<2,500 g) was associated with an increased risk of T2DM (OR, 1.55; 95% CI, 1.39‑1.73; P4,000 g) and normal birth weight in terms of the risk of T2DM (OR, 0.98; 95% CI, 0.79‑1.22). Compared with high birth weight, low birth weight was associated with an increased risk of diabetes mellitus (OR, 1.58; 95% CI, 1.30‑1.93; P<0.001). These findings indicated that there may be an inverse linear association between birth weight and T2DM.
- 29 September 2017
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 14  (6) , 5313-5320
Open AccessBirth weight and type 2 diabetes: A meta‑analysis
The prevalence of T2DM is increasing around the world on a yearly basis. A meta‑analysis was conducted to analyze the association between birth weight and incidence of type 2 diabetes mellitus (T2DM). A literature search was performed from January 1990 to June 2016 in PubMed, ScienceDirect, SpringerLink, China National Knowledge Infrastructure and Chinese Biomedical Literature Database. After reviewing characteristics of all the included studies systematically, a meta‑analytical method was employed to calculate the pooled odds ratios (ORs) and associated 95% confidence intervals (CI) from random‑effects models. Heterogeneity was assessed by Q‑statistic test. Funnel plot, Begg's and Egger's linear regression tests were applied to evaluate publication bias. A sensitivity analysis was also performed to assess the robustness of results. According to inclusion and exclusion criteria, 8 studies were selected to be included in the meta‑analysis. Compared with normal birth weight (2,500‑4,000 g), low birth weight (<2,500 g) was associated with an increased risk of T2DM (OR, 1.55; 95% CI, 1.39‑1.73; P4,000 g) and normal birth weight in terms of the risk of T2DM (OR, 0.98; 95% CI, 0.79‑1.22). Compared with high birth weight, low birth weight was associated with an increased risk of diabetes mellitus (OR, 1.58; 95% CI, 1.30‑1.93; P<0.001). These findings indicated that there may be an inverse linear association between birth weight and T2DM.
- Open Access
- 20 April 2017
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 130  (8) , 936-942
Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
E SSTR2 and SSTR5 expression and observe structural changes in tumor tissue. Methods: We reviewed records and samples from eight TSHoma patients treated between July 2012 and July 2015. We tested immunohistochemically for SSTR2/5 expression and examined TSHoma cells for morphological changes. Signed rank sum test was used to compare the efficacy of short-term preoperative OCT treatment. Results: OCT treatment (median time: 7.9 days, range: 3–16 days; median total dose: 1.8 mg, range: 0.9–4.2 mg) led to significant decrease in all patients’ thyroid hormone levels (FT3 [nmol/L]: 8.33 [7.02, 12.29] to 4.67 [3.52, 5.37] [P = 0.008]; FT4 [pmol/L]: 25.36 [21.34, 28.99] to 16.66 [14.88, 21.49] [P = 0.016]; and TSH [μU/ml]: 5.80 [4.37, 6.78] to 0.57 [0.19, 1.24] [P = 0.008]). All the eight tumor specimens expressed high SSTR2 protein levels; 5/8 expressed high SSTR5, but 3/8 that expressed low SSTR5 presented a significantly higher TSH suppression rate (P = 0.036). Electron microscopy showed subcellular level impairments, including clumped nuclear chromatin and reduced cytoplasmic volume. Golgi complexes were observed in the OCT-treated TSHoma specimens. Conclusions: OCT can control hormone levels and damage the ultrastructure of tumor cells and organelles. Short-term response to OCT may be related to SSTR5 expression. Preoperative SST analog treatment for TSHoma could be considered as a combination therapy....
- 20 April 2017
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 130  (8) , 936-942
Open AccessShort-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
E SSTR2 and SSTR5 expression and observe structural changes in tumor tissue. Methods: We reviewed records and samples from eight TSHoma patients treated between July 2012 and July 2015. We tested immunohistochemically for SSTR2/5 expression and examined TSHoma cells for morphological changes. Signed rank sum test was used to compare the efficacy of short-term preoperative OCT treatment. Results: OCT treatment (median time: 7.9 days, range: 3–16 days; median total dose: 1.8 mg, range: 0.9–4.2 mg) led to significant decrease in all patients’ thyroid hormone levels (FT3 [nmol/L]: 8.33 [7.02, 12.29] to 4.67 [3.52, 5.37] [P = 0.008]; FT4 [pmol/L]: 25.36 [21.34, 28.99] to 16.66 [14.88, 21.49] [P = 0.016]; and TSH [μU/ml]: 5.80 [4.37, 6.78] to 0.57 [0.19, 1.24] [P = 0.008]). All the eight tumor specimens expressed high SSTR2 protein levels; 5/8 expressed high SSTR5, but 3/8 that expressed low SSTR5 presented a significantly higher TSH suppression rate (P = 0.036). Electron microscopy showed subcellular level impairments, including clumped nuclear chromatin and reduced cytoplasmic volume. Golgi complexes were observed in the OCT-treated TSHoma specimens. Conclusions: OCT can control hormone levels and damage the ultrastructure of tumor cells and organelles. Short-term response to OCT may be related to SSTR5 expression. Preoperative SST analog treatment for TSHoma could be considered as a combination therapy....